Medical devices, healthcare technology and the business of care
PMA SUPPLEMENT · P000009/S130

PSW 2601.U, NEO 2601.U, Acticor Sky DR-T, Rivacor Sky DR-T, Rivacor Rise DR-T, Rivacor Aura DR-T

Biotronik, Inc. · Decision date Sep 17, 2026

MEDTECHLEDGER EXPLANATIONP000009/S130

What did the FDA approve?

FDA's PMA database records decision APPR dated 2026-09-17 for P000009/S130, a real-time process supplement filed by Biotronik, Inc. The stated purpose is approval for updated programmer software PSW 2601.U and NEO 2601.U. The listed supplement reason is a change to design, components, specifications or material. The record ties this supplement to the original PMA number P000009, an implantable dual-chamber defibrillator filing under product code MRM in the cardiovascular specialty; devices named in the record title include Acticor Sky DR-T, Rivacor Sky DR-T, Rivacor Rise DR-T and Rivacor Aura DR-T.

The supplement concerns programmer software, not a new approval of the whole system. Beyond the software identifiers and the generic change category, the record does not state which software functions, components or specifications changed, nor the scope of the original PMA. The reported purpose is approval of updated programmer software; the entry does not itself report safety, performance or clinical effectiveness findings, and no such conclusions follow from the decision code alone.

FDA approval order statement

approval for updated programmer software PSW 2601.U and NEO 2601.U
Regulatory pathway
PMA supplement
Supplement type
Real-Time Process
Clinical specialty
Cardiovascular
Decision date
Sep 17, 2026
FDA change category
Change Design/Components/Specifications/Material

FDA source record · MedtechLedger’s explanation describes the recorded change.

Regulatory record facts

Identifier
P000009/S130
Regulatory pathway
PMA supplement
Product code
MRM
Decision code
APPR
Decision date
Sep 17, 2026
Source update
Nov 9, 2026
Original record
Open FDA source record

About this medical device

FDA device category: DEFIBRILLATOR, IMPLANTABLE, DUAL-CHAMBER.

Product code
MRM
FDA device class
3

For the original device and its historical approval scope, see PMA P000009. Subsequent supplements may change the device or its indications.

FDA decision timeline

  1. P000009 · Original PMA

    PHYLAX AV ICD SYSTEM

  2. P000009/S130 received

    Application receipt date recorded by FDA.

  3. P000009/S130 · FDA decision

    Real-Time Process

  4. P000009/S124 · Related supplement

    Ilivia Neo 7 DR-T 429529; Intica Neo 7 DR-T 429558; Intica Neo 5 DR-T 429568

  5. P000009/S133 · Related supplement

    Acticor Sky DR-T, Rivacor Sky DR-T, Rivacor Rise DR-T, Rivacor Aura DR-T, Acticor 7 DR-T, Rivacor 7 DR-T, Rivacor 5 DR-T

  6. P000009/S132 · Related supplement

    Acticor Sky DR-T 481987; Rivacor Sky DR-T 481982; Rivacor Rise DR-T 482018; Rivacor Aura DR-T 482014

  7. P000009/S134 · Related supplement

    Intica Neo 7 DR-T DF-1 ProMRI, Intica Neo 5 DR-T DF-1 ProMRI

  8. P000009/S135 · Related supplement

    Ilivia Neo 7 DRT, Intica Neo 7 DRT, Intica Neo 5 DRT, Acticor Sky DR-T, Rivacor Sky DR-T, Rivacor Rise DR-T, Rivacor Aur

Timeline entries are records held by MedtechLedger for P000009. View FDA’s full supplement list.

Related devices and submissions

Same PMA: P000009

Explore the linked device profile

Other records with product code MRM

A shared product code identifies a classification relationship; it does not establish clinical equivalence.

Regulatory context

A PMA supplement records a change to a device with an existing premarket approval. The supplement’s approval applies to the change described in that submission.

FDA describes the real-time supplement process as a review route for minor changes to a device, including certain design, software, sterilization or labeling changes.

Read our guide to FDA clearance and approval · FDA’s explanation of this pathway

Manufacturer intelligence

Biotronik, Inc.

Headquarters
Not reported
Brand website
Not reported
FDA applicant address
6024 Jean Rd., Lake Oswego, OR, 97035

Sources and methodology

FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.

How we use FDA records